Delivery Order SPE2DB22D1017-SPE2DB24FF5QY

Award Date 4/9/24
Potential Completion Date 4/10/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,987.86 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 22, 2024, with a completion date of July 23, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Advair HFA 115-21 MCG inhalers to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,048.33 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, located in Conshohocken, Pennsylvania. The contract has an ultimate completion date of April 2, 2024 and does not include a set-aside designation. Amerisourcebergen Drug...
This federal contract award is for the delivery of Advair HFA 45-21 MCG Inhaler 12GM, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $10,623.38 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, through its Corporate Office division located in Conshohocken, Pennsylvania. This order is part of a larger indefinite delivery contract...
This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $2,605.55, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support...
This contract award is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA). The $1,472.06 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distributor. The award does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award is for the delivery of Advair HFA 115-21 mcg inhalers to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, as a $4,759.31 firm fixed price delivery order. The contract has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is not associated with any set-aside designations. The company has...
This federal contract award is for the delivery of Advair HFA 230-21 mcg inhaler products to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award is a firm fixed price delivery order with a potential value of $9,292.96 and a completion date of February 21, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler, 12GM to the Defense Logistics Agency Troop Support Medical, a division of the Defense Logistics Agency. The $1,915.84 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract has a completion date of February 21, 2024 and was awarded on February 20, 2024. No set-aside designation was used for...
This federal contract award is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $11,217.14 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. This contract does not have a set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA) Troop Support Medical. The $20,334.80 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that was previously granted by DLA to Amerisourcebergen...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF5QY
    Delivery Order

This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,408.29 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The award has an ultimate completion date of April 10, 2024.

Amerisourcebergen Drug Corp has an existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order does not have a set-aside designation.

Generated 7/9/24, 1:43 PM